MOESM1 of Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

Additional file 1. Supplemental data on cholesterol efflux capacity and bioimpedance vector analysis.